Doing it our way now: the approach this company pioneered is becoming the market's way
The model's full reasoning — Q3 2021 call → NOWe need to determine if management describes that their way of doing things is being adopted, copied, or moved toward by others in the market. The transcript discusses vadadustat, a HIF-PHI for anemia in CKD. They mention that they are first to market, and that competitors like roxadustat and daprodustat have data. They note that daprodustat data confirms that the issues seen with roxadustat were not class effects, and that these products can be used safely. They also mention that physicians are likely to prescribe HIF-PHIs. However, is there any indication that others are adopting their specific approach? They talk about being first, but not about others copying their method. They mention that the market is growing, but not that others are following their lead. They also mention that they have a distribution relationship with Vifor to access Fresenius, but that's not about others adopting their way. The question is about whether the company's way of doing things is becoming the market's way. Management does not describe competitors adopting their specific approach, product design, or business model. They talk about being first, but not about others following. They also mention that daprodustat data supports their approach, but that's not about others copying them. They say "we believe vadadustat can have a significant impact" and "we are excited about vadadustat's potential to be the first-in-class HIF-PHIs in the US." That's about being first, not about others following. They also mention that physicians are likely to prescribe HIF-PHIs, but that's a general trend, not specifically because of their company. They do not describe any concrete instance of others adopting their way. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| USFD | US Foods Holding Corp. | Q1 2018 | 2018-05-12 | C |
| SHOO | Steven Madden, Ltd. | Q1 2017 | 2017-04-21 | C |
AES · Q1 2024 → YESThe question is: Does management describe that the WAY THIS COMPANY DOES THINGS is NOW BEING ADOPTED, COPIED, OR MOVED TOWARD BY OTHERS IN ITS MARKET, so that the company's own way of doing things is ...
GGR · Q1 2023 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?
TGT · Q4 2022 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?